Nurse Practitioner, Adult Health · Elmhurst, NY
NPI
1548341167
Since 2006
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7901 Broadway
Elmhurst, NY, 11373
Phone (718) 334-2138
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$128K
1,059 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Sinae Jung prescribed most often to Medicare patients was Lidocaine, with 222 prescriptions and refills. In total Sinae Jung wrote 1,059 Medicare prescriptions that cost $128K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lidocaine Generic | 222 | 260 | 58 | $54K |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 162 | 162 | 38 | $7,486 |
| Gabapentin Generic | 157 | 165 | 37 | $2,337 |
| Baclofen Generic | 136 | 150 | 41 | $651 |
| Diclofenac Epolamine Generic | 75 | 84 | 21 | $38K |
| Fluocinonide Generic | 46 | 46 | 13 | $7,807 |
| Piroxicam Generic | 33 | 33 | 11 | $5,562 |
| Pregabalin Generic | 32 | 32 | Under 11 | $2,039 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 31 | 31 | 12 | $1,790 |
| Nortriptyline Hcl Generic | 31 | 31 | Under 11 | $83.69 |
| Diclofenac Sodium Generic | 29 | 31 | 11 | $294 |
| Methocarbamol Generic | 24 | 27 | Under 11 | $130 |
| Tizanidine Hcl Generic | 21 | 21 | Under 11 | $282 |
| Naproxen Generic | 12 | 12 | Under 11 | $159 |
| Tramadol Hcl Generic | 12 | 12 | Under 11 | $98.06 |
Brand drugs: 265 claims; generic drugs: 794 claims; opioid claims: 24.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sinae Jung were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.